Human genetic mutations that lead to excessive IL-1 release or defective IL-1Ra-mediated regulation are associated with autoinflammatory syndromes, which are often characterized by fever, rheumatoid arthritis, psoriatic-like skin conditions, and atherosclerosis [2, 254]. Here, IL1A is linked to rheumatoid arthritis.